2023
DOI: 10.36628/ijhf.2023.0027
|View full text |Cite
|
Sign up to set email alerts
|

Differences in Leukocyte Transcriptomes of Morbidly Obese Patients With High Output Heart Failure: A Pilot Study

Samantha A. Cintron,
Janet Pierce,
Mihaela E. Sardiu
et al.

Abstract: Background and Objectives Heart failure is characterized by alterations of gene expression that provide insight into the underlying pathophysiologic mechanisms. However, obesity-related high output heart failure (HOHF) is a specific phenotype of heart failure that has not been studied using gene expression. Our aim in this study was to examine the variances in leukocyte transcriptomes of morbidly obese patients with HOHF. Methods In this cross-sectional study, we applie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…In the latest issue of the International Journal of Heart Failure , Cintron et al 9) conducted a pilot and cross-sectional study to examine the variances in leukocyte transcriptomes of morbidly obese patients with HOHF and attempted to provide insight into the underlying pathophysiologic mechanisms. Gene expression analyses showed the upregulation of 114 genes and downregulation of 2 genes in morbidly obese and HOHF patients compared to the gene expressions in morbidly obese and non-HOHF patients.…”
mentioning
confidence: 99%
“…In the latest issue of the International Journal of Heart Failure , Cintron et al 9) conducted a pilot and cross-sectional study to examine the variances in leukocyte transcriptomes of morbidly obese patients with HOHF and attempted to provide insight into the underlying pathophysiologic mechanisms. Gene expression analyses showed the upregulation of 114 genes and downregulation of 2 genes in morbidly obese and HOHF patients compared to the gene expressions in morbidly obese and non-HOHF patients.…”
mentioning
confidence: 99%